Tag Archives: Supreme Court

Canadian Hospital To Travel The Long And Winding Road Of “Gene Patenting”

Posted on November 3, 2014 by Warren Woessner

Arguing that human DNA is a natural product, the Children’s Hospital of Eastern Ontario (CHEO) has filed suit in Federal Court to invalidate patents claiming human DNA or diagnostic methods that use it. It has been reported that CHEO was … Continue reading →

Posted in Canadian Practice | Tagged , , , , , , , , , , | Leave a comment

Genetic Technologies v. LabCorp. – Mayo Redux.

Posted on September 16, 2014 by Warren Woessner

It was Mayo redux with a vengeance in the September 23, 2014 decision in Genetic Technologies Ltd. v. Laboratory Corp. of Amer. Holdings et al., Civil Action No. 12-1736-LPS-CJB (D. Del. 2014).  Magistrate Judge Burke released an opinion invalidating claim … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , | 2 Comments

Takeaways from Seattle Summer 2014 Seminars

Posted on August 25, 2014 by Warren Woessner

A guest post by Donald Chisum and Janice Mueller. In August 2014 the Chisum Patent Academy held two back-to-back seminars in its Seattle, Washington facility to discuss and debate current developments in patent law. Each roundtable seminar group was limited … Continue reading →

Posted in Conferences and Classes | Tagged , , , , , , | Leave a comment

Nautilus v. Biosig – Solving Insoluble Ambiguity?

Posted on June 2, 2014 by Warren Woessner

Today the Supreme Court unanimously rejected the Fed. Cir.’s standard for resolving challenges to validity under s.112 para.2, based on whether or not a claim was “amenable to construction” and not “insolubly ambiguous”. Noting that Nautilus had urged that a patent … Continue reading →

Posted in Section 112(2) - Indefiniteness | Tagged , , , , , | 1 Comment